FDA Warns Against Combining Remdesivir And Hydroxychloroquine

Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.

FDA Warns Against Combining Remdesivir And Hydroxychloroquine

W
Wochit Business

0 Views • Jun 16, 2020

Description

The FDA has issued a warning to healthcare providers regarding two medications being tested with COVID-19.
The warning cautions against administering hydroxychloroquine in combination with remdesivir.
According to Reuters, the agency said the co-administration may result in the reduced effectiveness of remdesivir.
Remdesivir is currently the only medication to show benefits against COVID-19 in clinical trials.
The warning comes hours after the FDA revoked emergency permission to use hydroxychloroquine to treat COVID-19.